<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03408808</url>
  </required_header>
  <id_info>
    <org_study_id>1/091/17</org_study_id>
    <nct_id>NCT03408808</nct_id>
  </id_info>
  <brief_title>Dorsal Wrist Ganglia; Aspiration Alone vs Aspiration and Injection of Platelet Rich Plasma</brief_title>
  <official_title>Dorsal Wrist Ganglia; Aspiration Alone vs Aspiration and Injection of Platelet Rich Plasma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aberdeen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Grampian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arthrex, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aberdeen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to examine the efficacy of Platelet Rich Plasma (PRP) to reduce recurrence in dorsal
      wrist ganglia (DWG). We will compare aspiration alone and aspiration with injection of PRP.

      We plan to recruit a maximum of 200 patients. We will assess the efficacy by contacting the
      patients by email or telephone at 6 weeks and 12 months. They will be asked to complete a
      questionnaire and a Patient Evaluated Measure score (PEMS). Adverse events will be screened
      for/ managed by a telephone call +/- review as necessary between 7 and 14 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patient selection All hand referrals vetted by Mr Lawrie or Miss Miller, those for
           dorsal wrist ganglia sent a letter of invitation and patient information. Patients
           responding to the letter with interested given an appointment at a special trial clinic.

           Contact details will be provided to allow any issues to be clarified discussed before
           attendance at clinic if the patient desires.

        2. Assess eligibility/ enrolment in study - clinic visit 1

             1. All patients assessed by the chief investigator Mr David Lawrie (DFML) or Miss
                Katharine Hamlin (KH).

             2. Clinical assessment of presence of ganglion.

             3. Ensure not meeting exclusion criteria.

             4. If eligible and willing to complete study commitments discuss study and answer
                questions.

             5. Once we are happy the patient has understanding of the study and its risks then the
                patient will be asked if they wish to enrol or if they would like more time to
                consider.

             6. If they are willing to participate they will then be offered treatment in the same
                visit or a return visit

        3. Intervention - clinic visit 1 or 2

             1. Check understanding and continuing desire to participate in study if 2nd visit.

             2. Complete consent form.

             3. Patient fills out a PEM score and demographics collected on SOS (Surgical Outcomes
                System - Arthrex).

             4. Randomisation.

             5. If in PRP group 15ml blood sample taken with Arthrex ACP double syringe and
                processed (see processing instructions in Appendix.9.

             6. Aspiration.

             7. If in PRP group - Injection of PRP (the same volume as aspirated).

             8. Pressure dressing with gauze, wool and crepe for 48 hours.

        4. Adverse event screening/ management Patients are offered two options at the treatment
           visit.

      1. Routine review at 10 - 14 days at the clinic or 2. Telephone review at 7 days by Miss
      Katharine Hamlin who will have performed the procedure.

      On telephone review if the patient is entirely happy that there are no concerns then follow
      up will proceed by email or telephone as below.

      If any concerns are raised, or if the patient desires, a face to face review will be arranged
      ideally within 24 hours but no longer than 72 hours. Recurrence or other outcomes will not be
      assessed at this time.

      5. SOS/ Email/ Telephone interview - 1 (6 weeks)

      a) Ganglion questionnaire b) PEM score c) Note any adverse events

      6. SOS/ Email /Telephone interview - 2 (12 months)

        1. Ganglion questionnaire

        2. PEM score

        3. Note any adverse events
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomisaed controlled trial with two arms. Control - Aspiration alone. Intervention - aspiration plus injection of platelet righ plasma.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The outcomes assessor will be blinded to the treatment received.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>6 weeks</time_frame>
    <description>Has the ganglion returned?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>12 months</time_frame>
    <description>Has the ganglion returned?</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PEM Score</measure>
    <time_frame>6 weeks</time_frame>
    <description>Patient reported measure of hand symptoms and function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PEM Score</measure>
    <time_frame>12 months</time_frame>
    <description>Patient reported measure of hand symptoms and function</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Ganglion of Wrist</condition>
  <arm_group>
    <arm_group_label>Aspiration alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will have their dorsal wrist ganglion aspirated and then pressure dressing for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspiration plus platelet rich plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will have their dorsal wrist ganglion aspirated, and then injected with platelet rich plasma (derived from a blood sample taken at the same visit) and then pressure dressing for 48 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet rich plasma</intervention_name>
    <description>Aspiration of ganglion and injection with platelet rich plasma.</description>
    <arm_group_label>Aspiration plus platelet rich plasma</arm_group_label>
    <other_name>PRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aspiration alone</intervention_name>
    <description>Aspiration of the ganglion</description>
    <arm_group_label>Aspiration alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Solitary dorsal wrist ganglion.

        Exclusion Criteria:

          -  Underlying wrist or ipsilateral arm pathology.

          -  Unable to consent to treatment.

          -  Unable or unwilling to attend follow up visits.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katharine Hamlin, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>NHS Grampian</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patricia Burns</last_name>
    <phone>+441224554362</phone>
    <email>researchgovernance@abdn.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>NHS Grampian</name>
      <address>
        <city>Aberdeen</city>
        <zip>AB25 2ZB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patricia Burns</last_name>
      <phone>1224554362</phone>
    </contact>
    <investigator>
      <last_name>Katharine Hamlin, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Meena S, Gupta A. Dorsal wrist ganglion: Current review of literature. J Clin Orthop Trauma. 2014 Jun;5(2):59-64. doi: 10.1016/j.jcot.2014.01.006. Epub 2014 Jun 3. Review.</citation>
    <PMID>25983472</PMID>
  </reference>
  <reference>
    <citation>Janzon L, Niechajev IA. Wrist ganglia. Incidence and recurrence rate after operation. Scand J Plast Reconstr Surg. 1981;15(1):53-6.</citation>
    <PMID>7268314</PMID>
  </reference>
  <reference>
    <citation>Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004 Apr;62(4):489-96. Review.</citation>
    <PMID>15085519</PMID>
  </reference>
  <reference>
    <citation>Freymiller EG, Aghaloo TL. Platelet-rich plasma: ready or not? J Oral Maxillofac Surg. 2004 Apr;62(4):484-8. Review.</citation>
    <PMID>15085518</PMID>
  </reference>
  <reference>
    <citation>Yu W, Wang J, Yin J. Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury. Int J Neurosci. 2011 Apr;121(4):176-80. doi: 10.3109/00207454.2010.544432. Epub 2011 Jan 19.</citation>
    <PMID>21244302</PMID>
  </reference>
  <reference>
    <citation>Valente Duarte de Sousa IC, Tosti A. New investigational drugs for androgenetic alopecia. Expert Opin Investig Drugs. 2013 May;22(5):573-89. doi: 10.1517/13543784.2013.784743. Epub 2013 Apr 4. Review. Erratum in: Expert Opin Investig Drugs. 2015 May;24(5):735.</citation>
    <PMID>23550739</PMID>
  </reference>
  <reference>
    <citation>Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225-8.</citation>
    <PMID>11813662</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2018</study_first_submitted>
  <study_first_submitted_qc>January 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2018</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wrist</keyword>
  <keyword>ganglion</keyword>
  <keyword>platelet rich plasma</keyword>
  <keyword>aspiration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ganglion Cysts</mesh_term>
    <mesh_term>Synovial Cyst</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

